Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population

被引:111
作者
Pasanen, Marja K.
Backman, Janne T.
Neuvonen, Pertti J.
Niemi, Mikko
机构
[1] Univ Helsinki, Dept Clin Pharmacol, Helsinki 00029, Finland
[2] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland
关键词
SLCO1B1; OATP1B1; polymorphism; haplotype; pharmacogenetics;
D O I
10.1007/s00228-006-0123-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Organic anion transporting polypeptide 1B1 (OATP1B1) is a drug uptake transporter located at the sinusoidal membrane of hepatocytes. Our aim was to establish high-throughput genotyping assays for the major known single nucleotide polymorphisms (SNP) in the SLCO1B1 gene encoding OATP1B1 and to investigate the frequencies of SNPs and haplotypes of SLCO1B1 in a large Caucasian population. Methods: Distribution of SLCO1B1 alleles was determined in 468 healthy Finnish Caucasian subjects at 11 variant sites spanning the entire gene by using allelic discrimination with TaqMan 5' nuclease assays. Results: The allelic frequencies of SLCO1B1 SNPs were 9.7% for g.-11187G > A, 0.4% for g.-11110T > G, 8.0% for g.-10499A > C, 46.2% for c.388A > G, 13.1% for c.411G > A, 13.1% for c.463C > A, 20.2% for c.521T > C, 53.2% for c.571T > C, 46.4% for c.597C > T, 4.0% for c.1929A > C and 48.8% for c.*439T > G. Altogether, 26 haplotypes were statistically inferred. The most common haplotype, with a frequency of 35.6%, contained variant allele C at position c.571, but had the reference nucleotide at all other positions investigated. The functionally significant c.521T > C SNP existed in four major haplotypes, which could be differentiated by the g.-11187G > A, g.-10499A > C and c.388A > G SNPs. The frequencies of these haplotypes were 7.9% for g.-11187G/g.-10499C/c.388G/c.521C (*16), 6.9% for AAGC (*17), 2.7% for GAAC (*5) and 2.4% for GAGC (*15). Conclusion: Sequence variations of SLCO1B1 occur at high frequencies in the Caucasian population. Further studies are needed to characterise the effects of SLCO1B1 haplotypes, especially *16, *17, *15 and *5, on drug pharmacokinetics and response, and to determine the frequencies of SLCO1B1 SNPs and haplotypes in different populations.
引用
收藏
页码:409 / 415
页数:7
相关论文
共 25 条
[1]   Effect of OATPIBI (SLCOIBI) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers [J].
Chung, JY ;
Cho, JY ;
Yu, KS ;
Kim, JR ;
Oh, DS ;
Jung, HR ;
Lim, KS ;
Moon, KH ;
Shin, SG ;
Jang, IJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) :342-350
[2]   PERFORMING THE EXACT TEST OF HARDY-WEINBERG PROPORTION FOR MULTIPLE ALLELES [J].
GUO, SW ;
THOMPSON, EA .
BIOMETRICS, 1992, 48 (02) :361-372
[3]   Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans [J].
Hirano, M ;
Maeda, K ;
Shitara, Y ;
Sugiyama, Y .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :139-146
[4]   Transporters and drug therapy: Implications for drug disposition and disease [J].
Ho, RH ;
Kim, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (03) :260-277
[5]   A novel human hepatic organic anion transporting polypeptide (OATP2) - Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters [J].
Hsiang, BN ;
Zhu, YJ ;
Wang, ZQ ;
Wu, YL ;
Sasseville, V ;
Yang, WP ;
Kirchgessner, TG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (52) :37161-37168
[6]  
Huang Ching-Shan, 2005, Pharmacogenet Genomics, V15, P43, DOI 10.1097/01213011-200501000-00007
[7]   Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects [J].
Ieiri, I ;
Suzuki, H ;
Kimura, M ;
Takane, H ;
Nishizato, Y ;
Irie, S ;
Urae, A ;
Kawabata, K ;
Higuchi, S ;
Otsubo, K ;
Sugiyama, Y .
HEPATOLOGY RESEARCH, 2004, 30 (02) :91-95
[8]   Cyclosporine markedly raises the plasma concentrations of repaglinide [J].
Kajosaari, LI ;
Niemi, M ;
Neuvonen, M ;
Laitila, J ;
Neuvonen, PJ ;
Backman, JT .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) :388-399
[9]   Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells [J].
Kameyama, Y ;
Yamashita, K ;
Kobayashi, K ;
Hosokawa, M ;
Chiba, K .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (07) :513-522
[10]   Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment [J].
Lee, E ;
Ryan, S ;
Birmingham, B ;
Zalikowski, J ;
March, R ;
Ambrose, H ;
Moore, R ;
Lee, C ;
Chen, YS ;
Schneck, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (04) :330-341